Cannabis reforms offer hope to CBD manufacturers around the world
Decisions by the UN and the European Commission to rehabilitate cannabis and cannabidiol could mean looser regulation for CBD products in countries across the world.
List view / Grid view
Decisions by the UN and the European Commission to rehabilitate cannabis and cannabidiol could mean looser regulation for CBD products in countries across the world.
The European Commission is reviewing whether CBD should be classified as a narcotic. Dr Parveen Bhatarah, Head of Regulatory and Compliance Unit at The Association of the Cannabinoid Industry, explains the impact this could have on both the European and UK markets.
Members from the Association for the Cannabinoid Industry (ACI) recently raised questions regarding CBD novel food dossier applications in the UK, and the FSA has now responded to their questions in a Q&A.
The Association for the Cannabinoid Industry (ACI) claims there is a need for standardisation and harmonisation of the analytical methodology protocols used in the testing of cannabinoids.
With the deadline for novel food authorisation on the horizon for UK CBD companies, Shomi Malik, Development Director at The Association for the Cannabinoid Industry (ACI), outlines the steps that must be taken to ensure dossiers meet the required standards.